======= GUCA2B ======= == Gene Information == * **Official Symbol**: GUCA2B * **Official Name**: guanylate cyclase activator 2B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2981|2981]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q16661|Q16661]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GUCA2B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GUCA2B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601271|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Endogenous activator of intestinal guanylate cyclase. It stimulates this enzyme through the same receptor binding region as the heat-stable enterotoxins. May be a potent physiological regulator of intestinal fluid and electrolyte transport. May be an autocrine/paracrine regulator of intestinal salt and water transport. |Guanylin| |guanylate cyclase activator activity| |calcium sensitive guanylate cyclase activator activity| |positive regulation of guanylate cyclase activity| |regulation of guanylate cyclase activity| |positive regulation of cyclase activity| |positive regulation of purine nucleotide biosynthetic process| |positive regulation of nucleotide biosynthetic process| |positive regulation of lyase activity| |cGMP-mediated signaling| |regulation of purine nucleotide biosynthetic process| |regulation of nucleotide biosynthetic process| |excretion| |regulation of cyclase activity| |positive regulation of purine nucleotide metabolic process| |positive regulation of nucleotide metabolic process| |negative regulation of blood pressure| |regulation of lyase activity| |photoreceptor outer segment| |body fluid secretion| |digestion| |regulation of purine nucleotide metabolic process| |regulation of nucleotide metabolic process| |positive regulation of small molecule metabolic process| |cyclic-nucleotide-mediated signaling| |regulation of blood pressure| |second-messenger-mediated signaling| |blood circulation| |circulatory system process| |regulation of small molecule metabolic process| |regulation of body fluid levels| |secretion| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of catalytic activity| |intracellular signal transduction| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |extracellular region| |system process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|-2.29| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|-1.98| |[[:results:exp100|NFN1 1μM R03 exp100]]|-1.82| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.77| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.75| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|-1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8032 * **Expression level (log2 read counts)**: -1.85 {{:chemogenomics:nalm6 dist.png?nolink |}}